Two new crystal protein genes, cry19A and orf2, isolated from Bacillus thuringiensis subsp. jegathesan were cloned and characterized. The cry19A gene encodes a 74.7-kDa protein, and the orf2 gene encodes a 60-kDa protein. Cry19A contains the five conserved blocks present in most B. thuringiensis ␦-endotoxins. The ORF2 amino acid sequence is similar to that of the carboxy terminus of Cry4 proteins. The cry19A gene was expressed independently or in combination with orf2 in a crystal-negative B. thuringiensis host. The proteins accumulated as inclusions. Purified inclusions containing either Cry19A alone or Cry19A and ORF2 together were toxic to Anopheles stephensi and Culex pipiens mosquito larvae. They were more toxic to C. pipiens than to A. stephensi. However, inclusions containing Cry19A and ORF2 together were more toxic than inclusions of Cry19A alone but less toxic than the wild-type inclusions of B. thuringiensis subsp. jegathesan.
Bacillus thuringiensis subsp. israelensis and Bacillus sphaericus are entomopathogenic bacteria. During sporulation, both produce crystals that are toxic to dipteran larvae after ingestion. B. thuringiensis subsp. israelensis crystals are composed of four major polypeptides of 135, 125, 68, and 27 kDa; crystals from B. sphaericus are composed of only two proteins of 51 and 42 kDa (for a review, see reference 21) .
Products from these two bacteria have been successfully used in various countries as a biological control agent for mosquito and blackfly larvae (18, 32) . However, in the last three years, field populations of insects have developed resistance to B. sphaericus (23, 27) . Although no resistance to B. thuringiensis subsp. israelensis in the field has been observed yet, laboratory selections using cloned B. thuringiensis subsp. israelensis toxins showed that development of resistance is likely to occur; this is inversely correlated with the number of toxins used for selection (11) . Thus, the effectiveness of existing bacteria could be improved by combining different toxins (from B. thuringiensis subsp. israelensis and/or new mosquitocidal bacteria) in a single organism (B. sphaericus, for example). Efforts are now focused on the identification of other mosquitocidal toxins, differing in structure and mode of action from those produced by B. thuringiensis subsp. israelensis and B. sphaericus.
There have been several reports of other mosquitocidal B. thuringiensis strains of various serotypes, including B. thuringiensis subsp. jegathesan 367 (serotype H28a28c), isolated from Malaysia (26) . B. thuringiensis subsp. jegathesan is as toxic as B. thuringiensis subsp. israelensis to Anopheles stephensi but is slightly less toxic to Aedes aegypti and Culex pipiens. Crystals from B. thuringiensis subsp. jegathesan contain seven major polypeptides with molecular masses of 80, 70 to 72, 65, 37, 26, and 16 kDa (22) . No B. thuringiensis subsp. israelensis-related gene has been detected in this strain, suggesting that the crystal proteins could be encoded by new classes of toxin genes (22) . Only the gene encoding the 80-kDa polypeptide (Cry11B) has been cloned (10) . Inclusions containing the Cry11B protein alone were as toxic as wild-type inclusions from B. thuringiensis subsp. jegathesan to C. pipiens and A. stephensi and were more toxic than the wild type when tested against A. aegypti. Cry11B is not the major component of the B. thuringiensis subsp. jegathesan inclusions, so there could be other polypeptides in the native crystals involved in toxicity, especially to A. stephensi and C. pipiens. This paper reports the isolation, sequencing, and expression of the gene encoding the 65-kDa protein from B. thuringiensis subsp. jegathesan, hereafter referred to as cry19A, and a second gene, orf2. The deduced protein sequence of Cry19A contains the five conserved blocks present in all Cry1, Cry3, and Cry4 B. thuringiensis ␦-endotoxins (12) . The deduced ORF2 amino acid sequence is similar to that of the carboxy terminus of the Cry4 proteins. cry19A was expressed independently or in combination with orf2 in a crystal-negative B. thuringiensis host. The toxicity of the purified inclusions obtained was tested with three mosquito species.
MATERIALS AND METHODS
Bacterial strains and plasmid. Escherichia coli TG1 [K-12 ⌬(lac-proAB) supE thi hsdD5/FЈ (traD36 proA ϩ proB ϩ lacI q lacZ⌬M15)] was used as the host species. B. thuringiensis subsp. jegathesan 367 (from the IEBC Collection of the Unité des Bactéries Entomopathogènes) was used for purifying wild-type crystals and DNA for cloning experiments. B. thuringiensis subsp. thuringiensis SPL407 (serotype H1) was used as a recipient for transformation experiments (16) . The shuttle vector pHT315 (2) was used as a cloning vector. B. thuringiensis SPL407 was transformed by electroporation as described by Lereclus et al. (16) except that cells were grown in Luria-Bertani medium with shaking at 37°C until the optical density at 650 nm was 0.8. E. coli was transformed with plasmid DNA following CaCl 2 treatment as previously described (15) . The antibiotic concentrations for bacterial selection were 10 g of erythromycin per ml and 100 g of ampicillin per ml.
DNA manipulations. Restriction enzymes, Klenow fragment, T4 DNA ligase, and calf intestinal alkaline phosphatase were used as described by Sambrook et al. (25) and as recommended by the manufacturers.
Total DNA was isolated from B. thuringiensis subsp. jegathesan cells as previously described (24) . Plasmid DNA was extracted from E. coli by a standard alkaline lysis procedure (3) and further purified with a kit from Qiagen GmbH (Hilden, Germany). The DNA fragments were purified from agarose gels with a Prep A Gene DNA purification matrix kit (Bio-Rad, Hercules, Calif.).
PCR was performed in a volume of 100 l containing 0.1 nmol of oligonucleotide, 500 ng of DNA, 0.2 mM deoxynucleoside triphosphates, 1.5 mM MgCl 2 , 50 mM KCl, 20 mM Tris-HCl (pH 8.4), and 2 U of Taq polymerase (Gibco-BRL). PCR cycling conditions were as follows: 5 min at 95°C; 26 cycles of 1 min at 42°C, 2 min at 72°C, and 1 min at 95°C; and 1 cycle of 3 min at 42°C and 4 min at 72°C, in an MJ Research PTC-100 thermocycler.
Hybridization experiments were performed with Hybond N ϩ filters (Amersham, Buckinghamshire, United Kingdom). The DNA probes were labeled with peroxidase by using the ECL direct nucleic acid labeling system (Amersham). The DNA sequences were determined with an automatic sequencer (model 373A; Applied Biosystems). Genetics Computer Group sequence analysis software package programs were used (University of Wisconsin, Madison).
Cloning of the B. thuringiensis subsp. jegathesan 65-kDa toxin gene. The 65-kDa protein from B. thuringiensis subsp. jegathesan was transferred to Problot membranes (Applied Biosystems), and its amino-terminal sequence was determined (Laboratoire de Microséquençage des Protéines, Institut Pasteur, Paris, France) with an automatic sequencer (model 473; Applied Biosystems). The sequence of the first 15 amino acids (MHYYGNRNEYDILNA) was used to design a degenerate 26-mer oligonucleotide probe (26-mer jeg65 oligonucleotide), ATGCATTATTATGGIAATIGIAATGA. This oligonucleotide corresponds to the sequence between M (position 1) and E (position 9); deoxyinosine was used as a neutral base for all three-or fourfold degenerate positions. PCR was performed on B. thuringiensis subsp. jegathesan total DNA, using the 26-mer jeg65 oligonucleotide and a cry4A-specific oligonucleotide (positions 1128 to 1108 from the ATG initiation codon of the gene [AGGAGTAGTTTGCGCTT TTTC]). The resulting purified 3-kb PCR product was labeled with peroxidase and used as a probe in DNA hybridization experiments with restriction enzymedigested total DNA from B. thuringiensis subsp. jegathesan. The probe specifically hybridized to an EcoRI-PstI restriction fragment of approximately 3 kb.
Size-selected (2-to 4-kb) EcoRI-PstI fragments of B. thuringiensis subsp. jegathesan 367 DNA were inserted into the EcoRI-PstI site of the shuttle vector pHT315. Recombinant colonies of transformed E. coli TG1 were tested for hybridization with the labeled probe. The probe hybridized strongly to one colony which contained the pJEG65.1 plasmid. The restriction map of this plasmid was determined (see Fig. 1 ). It lacks the end of cry19A.
PCR was then performed with oligonucleotides D2 (GGATTTACGGGAGG AGATTTGG; positions 1827 to 1848 [see jegathesan to obtain a 326-bp PCR probe. This probe, containing the same sequence as the ClaI-EcoRI fragment of pJEG65.1, was used to identify a 7-kb HindIII fragment from B. thuringiensis subsp. jegathesan total DNA. This fragment was then ligated into pHT315 digested with HindIII to produce the pJEG65.2 plasmid (see Fig. 1 (14) containing erythromycin if required, with shaking at 30°C until cell lysis. Spores and crystals were harvested and washed once in 1 M NaCl and twice in cold doubledistilled water. The crystals were further purified on discontinuous sucrose gradients as previously described (29) . Crystal protein concentrations were measured by the Bradford assay (Bio-Rad) after alkaline solubilization of the extracts (9) . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed as described by Laemmli (13) .
Mosquitocidal activity assay. Mosquitoes from colonies of C. pipiens (strain Montpellier), A. aegypti (strain Bora-Bora), and A. stephensi (strain ST15) were reared in the laboratory at 26°C with 80% relative humidity and under a 14-hday/10-h-night photoperiod. Larvae were reared in dechlorinated water and fed with commercial cat biscuits. Purified inclusions were diluted in glass petri dishes containing 20 ml of deionized water and tested in duplicate against 20 fourthinstar larvae of C. pipiens and A. aegypti and second-instar larvae of A. stephensi. Each bioassay was repeated at least three times. Larval mortality after 48 h was recorded, and concentrations causing 50% mortality were determined by probit analysis.
Nucleotide sequence accession number. The nucleotide sequence data shown below (see Fig. 2 ) are available in the EMBL, GenBank, and DDBJ nucleotide sequence databases under accession no. Y07603.
RESULTS
Cloning experiments. The gene encoding the 65-kDa protein from B. thuringiensis subsp. jegathesan 367 (designated cry19A by the Cry Gene Nomenclature Committee [6a]) was isolated as described in Materials and Methods. A positive clone, E. coli(pJEG65.1), was selected; plasmid pJEG65.1 contains a 3.4-kb PstI-EcoRI DNA insert for which a restriction map was determined (Fig. 1) . The restriction map, hybridization with the 26-mer jeg65 oligonucleotide, and PCR experiments using the 26-mer jeg65 oligonucleotide and universal or reverse oligonucleotide primers showed that the cry19A gene was present on the SphI/EcoRI fragment. The upstream 1.3-kb SphI fragment was deleted from pJEG65.1 to give plasmid pJEG65.1S (Fig. 1) . Sequencing of plasmid pJEG65.1S showed that the cry19A gene was incomplete: no stop codon was found. The end of the gene was therefore cloned by inserting a 7-kb HindIII fragment into plasmid pJEG65.2 (Fig. 1) . The complete gene was then obtained by production of plasmid pJEG65.3 ( Fig. 1) as described in Materials and Methods.
Sequence analysis. The sequence of pJEG65.3 in the region containing the gene encoding the 65-kDa protein was determined on both strands. Two open reading frames oriented in the same direction and separated by 145 bp were identified (Fig. 2): cry19A (1,947 bp) and orf2 (1,581 bp) . A putative ribosome binding site, GGAGG, was identified 7 nucleotides upstream from the start codon of the cry19A gene (Fig. 2) , and a sequence, AAAGGTTGTG, that could act as a ribosome binding site was identified 6 nucleotides upstream from orf2 (Fig. 2) . ⌬Gs, calculated by comparison with the gram-positive consensus sequence (17) as described by Tinoco et al. (31), were Ϫ60.2 (for cry19A) and Ϫ50.2 (for orf2) kJ/mol. No typical promoter or terminator sequences were identified upstream or downstream from the two coding regions.
Cry19A is a polypeptide of 648 residues with a predicted mass of 74.7 kDa. ORF2 is a protein of 526 residues with a predicted mass of 60 kDa. The deduced amino acid sequences of the Cry19A and ORF2 polypeptides were compared with those of other known B. thuringiensis toxins. The Cry19A protein showed no similarity to the Cry11B protein of B. thuringiensis subsp. jegathesan (10) , and the only similarities to B. thuringiensis toxins were restricted to the five blocks conserved in most of the ␦-endotoxins (12) (Fig. 2) . The Cry4A and Cry10A ␦-endotoxins have the sequences most similar to Cry19A, but the similarity is confined to the first 51 amino acids (60% identity). No other significant similarity was found. This protein therefore belongs to a novel class of ␦-endotoxins. The deduced ORF2 amino acid sequence was 65% identical to the carboxy terminus of the Cry4 protein (Fig. 3) and 85% identical to the known partial sequence of ORF2 from B. thuringiensis subsp. israelensis (30) . ORF2 from B. thuringiensis subsp. jegathesan contains a stretch of 41 amino acids absent from the carboxy terminus of the Cry4 proteins.
Expression of cry19A and orf2 in a crystal-negative strain of B. thuringiensis. Plasmids pJEG65.5 ( Fig. 1) , which contains both the cry19A and the orf2 genes, and pJEG65.4 ( Fig. 1) , which contains the entire cry19 gene but only an incomplete orf2 gene, were constructed as described in Materials and Methods. These two plasmids and the vector pHT315 were independently introduced by electroporation into the crystalnegative strain B. thuringiensis 407 to determine the toxicity of their products. Recombinant 407(pJEG65.4), 407(pJEG65.5), and 407(pHT315) cells sporulated well in HCT medium and lysed after 48 h of growth. Small inclusions were visible under the light microscope for recombinants 407(pJEG65.4) and 407(pJEG65.5). These inclusions were purified on discontinuous sucrose gradients from recombinant clones collected by centrifugation at the end of sporulation. Purified inclusions were subjected to SDS-PAGE followed by staining with Coomassie brilliant blue. The banding patterns were compared with those produced by wild-type B. thuringiensis subsp. jegathesan (Fig. 4) . The major polypeptide in inclusions purified from recombinant strain 407(pJEG65.4) was approximately 65 kDa (Fig. 4, lane 2) , the same size as that found in the crystals of the toxic wild-type strain 367 (Fig. 4, lane 1) . Three major products of 65, 66, and 67 kDa were detected in inclusions purified from recombinant strain 407(pJEG65.5) (Fig. 4, lane  3) . The amino-terminal sequence of these polypeptides was determined by using the first five amino acids. The first five amino acids of the 65-kDa polypeptide were identical to the first five amino acids of the Cry19A predicted sequence. The two other proteins had the same amino-terminal sequence, identical to that of the orf2 product.
Larvicidal activity of the cry19A and cry19A-orf2 products. Purified inclusions from strains 407(pJEG65.4) and 407 (pJEG65.5) were assayed for activity against larvae of A. aegypti, A. stephensi, and C. pipiens as described in Materials and Methods. Crystals purified from wild-type strain B. thuringiensis subsp. jegathesan 367 were also tested. The activity of inclusions containing Cry19A alone or both Cry19A and ORF2 was restricted to A. stephensi and C. pipiens larvae (Table 1) , with greater toxicity to C. pipiens. None of the recombinant inclusions were toxic to A. aegypti larvae at a concentration of 400 g/ml. Inclusions containing both Cry19A and ORF2 were more toxic than those containing only Cry19A, about 24 times more toxic for A. stephensi and 55 times more toxic for C. pipiens. Inclusions containing Cry19A and ORF2 were less toxic than wild-type inclusions, about 28 times less toxic for A. stephensi and 9 times less toxic for C. pipiens.
DISCUSSION
We report the cloning and characterization of two new B. thuringiensis genes, cry19A and orf2, from B. thuringiensis subsp. jegathesan. The cry19A gene encodes a protein of 74.7 kDa, and the orf2 gene codes for a protein of 60 kDa. The Cry19A protein contains the five blocks that are conserved in the amino-terminal region of most ␦-endotoxins but has no other significant similarity to known toxins, other than the first 51 amino acids of Cry4A and Cry10A. This protein therefore belongs to a novel class of ␦-endotoxins. ORF2 is very similar to the carboxy-terminal region of the 130-kDa toxins. Thus, Cry19A and ORF2 have elements of primary structure in common with the 130-kDa ␦-endotoxins. Cry19A is similar to the variable amino-terminal half, and ORF2 is similar to the conserved carboxy-terminal half. This structure is comparable to those of Cry10A and ORF2 in B. thuringiensis subsp. israelensis, in which Cry10A has a sequence similar to the amino-terminal half of ␦-endotoxins and contains the five conserved blocks. The partial sequence of ORF2 is similar to the carboxy-termi- nal half of a 130-kDa toxin (8, 30) . The events leading to this configuration are unknown, but it may have evolved through the insertion of a DNA fragment into a gene that would otherwise encode a 130-kDa protein. This insertion could be the result of a transposition of a mobile element. We identified an open reading frame oriented in the opposite direction in the vicinity of orf2 (data not shown). Comparison of the deduced amino acid sequence with others in the Swiss-Prot data bank showed similarities with the putative transposase of insertion sequence IS240 from B. thuringiensis subsp. israelensis (7) . The inverted repeat sequence of this mobile element is present within the end of the coding frame of orf2 (Fig. 2) . This could explain the stretch of 41 amino acids present in ORF2 and absent from the carboxy-terminal region of the Cry4 proteins. Two copies of IS240 flank the cry4A gene in B. thuringiensis subsp. israelensis (4, 7) . One copy of the IS240-related insertion element was found upstream from the cry11B gene in B. thuringiensis subsp. jegathesan (10) , and the other was found close to the cyt1Ab1 gene from B. thuringiensis subsp. medellin (28) . IS240-related sequences are present in all the diptera-toxic strains of B. thuringiensis tested (24) . Although no transposition event has yet been demonstrated for this element, IS240-like insertion sequences may account for the dispersion of toxin genes in various B. thuringiensis strains.
The regulation of cry19A and orf2 gene expression has not yet been studied. Sequence analysis of the region upstream from orf2 did not detect any B. thuringiensis consensus promoter. The two open reading frames are separated by only 145 bp and are oriented in the same direction, so they could be part of the same operon. Experiments are in progress to determine the length of this putative operon and to identify the sigma factor(s) involved in its expression.
Inclusions containing either Cry19A alone or Cry19A and ORF2 together were toxic to C. pipiens and A. stephensi. However, inclusions containing only Cry19A were less toxic than inclusions containing both Cry19A and ORF2. This suggests that either Cry19A and ORF2 are both toxic and could act in synergy, as previously described for B. thuringiensis subsp. israelensis proteins Cry4A, Cry4B, Cry11A, and Cry10A (1, 6, 8, 9, 20) , or Cry19A is the only toxic polypeptide and ORF2 interacts with Cry19A at a transcriptional or posttranscriptional level, increasing the toxicity. The second hypothesis is more likely, as Cry19A is poorly expressed on its own and appears degraded in SDS-PAGE analysis. More Cry19A is produced when ORF2 is produced simultaneously (data not shown). The presence of orf2 may stabilize the mRNA, or ORF2 may act as a chaperone to increase the stability of Cry19A. The carboxy-terminal region of the 130-kDa toxins, similar to ORF2, is not essential for toxicity of Cry4B. Only the amino-terminal fragment, similar to Cry19A in terms of structure (five conserved blocks), retained full activity (5, 8, 19) . This suggests that the carboxy-terminal region is involved in stability rather than toxicity. We are investigating the effect of ORF2 on the toxicity and stability of Cry19A.
Although the combination of Cry19A and ORF2 is more toxic than Cry19A alone, it is less toxic than the wild-type inclusions of B. thuringiensis subsp. jegathesan. It was also totally inactive against A. aegypti, which is sensitive to the wild-type crystals. This shows that several polypeptides may be responsible for B. thuringiensis subsp. jegathesan activity. Cry11B, the first characterized polypeptide from B. thuringiensis subsp. jegathesan, is highly toxic to A. aegypti, C. pipiens, and A. stephensi (10) . The spectra and levels of activity of Cry11B and of Cry19A plus ORF2 are different. Thus, the high toxicity of the wild-type B. thuringiensis subsp. jegathesan crystals may be the result of additive or synergistic interactions between these polypeptides. Further studies are needed to investigate the nature of these interactions. 
